查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1857665

萤光内视镜市场按产品类型、应用和最终用户划分 - 全球预测 2025-2032

Fluorescence Endoscopy Market by Product Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，萤光视镜市场规模将达到 163.8 亿美元，复合年增长率为 8.20%。

关键市场统计数据
基准年 2024 87.2亿美元
预计年份：2025年 94.5亿美元
预测年份 2032 163.8亿美元
复合年增长率 (%) 8.20%

本书简明扼要地说明了萤光视镜技术，重点阐述了成像化学、仪器小型化和临床工作流程如何融合，从而重新定义手术视觉化。

萤光导引内视镜已从一种辅助影像技术发展成为临床应用的重要工具，它正在重塑临床医生在侵入性诊断和治疗过程中观察组织病理的方式。过去十年间，标靶光学探针、小型化成像硬体和即时影像增强技术的进步，共同提高了病灶的检出率和术中决策的准确性。这些技术进步并非简单的渐进式改进，而是透过实现更精准的切片检查、更清晰的切除边缘界定以及针对高风险患者的强化监测通讯协定，正在彻底改变临床工作流程。

临床医生和采购团队目前正从多个角度评估萤光内视镜解决方案，包括光学性能、探针化学性质、与现有内视镜设备的互通性以及后续的培训和维护需求。从创新角度来看，我们看到生物化学和工程学正在融合。针对特定生物标记设计的分子探针正与优化后的成像平台相匹配，这些平台旨在最大限度地提高信噪比，同时保持手术操作的便利性。因此，最终的采纳决策越来越依赖已证实的临床效用和操作相容性，而非单纯的资本购买。

本导言为深入分析技术曲折点、监管动态、报销现状和推广障碍奠定了基础。接下来的章节将详细阐述这些因素如何相互作用，政策转变和关税环境如何改变供应链，以及相关人员可以采取哪些策略措施来获取萤光内视镜的临床和商业性价值。

探针特异性、可互通成像平台、人工智慧驱动软体以及以服务为中心的商业模式的进步如何重新定义临床应用动态

除了硬体升级之外，萤光视镜领域正再形成探针化学、软体智慧和服务交付模式等方面的多项变革性转变。首先，光学探针设计已从频谱染料发展到靶向分子特征的高特异性生物探针，从而提高了对比度并减少了假阳性结果。这项转变有助于术中决策更加精准，并与治疗流程更加紧密地整合。其次，成像平台变得更加模组化和互通性，使诊所能够将萤光功能添加到现有的内视镜塔上，或部署紧凑型手持设备用于床边操作。

同时，软体和演算法的改进变得至关重要。影像处理软体目前专注于即时增强、定量讯号映射以及与手术记录系统的整合。人工智慧和机器学习工具正被越来越多地应用于辅助病灶检测和标准化判读，从而减少操作者差异并缩短学习曲线。服务模式也在不断发展。供应商现在将维护、培训服务和远端软体更新捆绑在一起，以确保性能稳定和持续的收入来源。

这种转变促进了化学家、影像技师和临床团队之间的跨学科合作，同时也促使医院管理者重新思考筹资策略，以平衡资本投资与长期服务和耗材。因此，萤光视镜领域正朝着一个优先考虑临床疗效、营运效率和可扩展支援结构的平台发展。

评估美国关税调整（直至2025年）如何重塑萤光视镜价值链的采购、供应商策略和营运韧性。

美国已实施或调整至2025年的关税措施的累积影响，为萤光内视镜价值链上的相关人员带来了许多营运和策略方面的考量。关税措施影响了进口成像组件、精密光学元件以及仪器和耗材中使用的专用製造原料的成本结构。对于那些在全球范围内采购关键组件的製造商而言，这些措施迫使他们重新评估供应商布局、合约条款和库存策略，以降低成本波动和潜在的供应中断风险。

从采购角度来看，医疗机构必须权衡不断上涨的进口相关成本与临床优先事项和预算限制之间的关係。在某些情况下，医院和门诊中心延长了资产使用寿命或优先采购，以尽量减少受影响供应链的影响。对于规模较小的医疗设备供应商和探针开发商而言，关税上涨加大了他们在地化生产或与经销商协商关税转嫁安排的压力，从而改变了他们的利润结构和投资计画。

关税引发的供应商变更导致监管和合规团队面临额外的行政负担，他们需要重新确认零件并更新设备主资料。此外，关税环境加速了关于近岸外包和策略伙伴关係的讨论，这些合作优先考虑的是供应链的韧性而非短期成本效益。总而言之，这些影响改变了整个生态系统的资本配置、合约承诺和供应链规划，促使企业在采购、定价和营运连续性方面做出更审慎的决策。

透过对产品类型、临床应用和最终用户需求进行深度细分，将产品与策略商业化和临床证据优先事项连结起来。

细分市场的动态变化清楚地揭示了产品、应用和终端用户采纳的路径，为商业化和临床策略提供了基础。根据产品类型，市场动态可分为耗材、仪器以及软体和服务。耗材部分包括用于靶向可视化和增强手术特异性的生物探针和萤光染料。仪器部分包括胶囊内视镜系统、软式内视镜和手持式仪器，提供适用于各种临床环境的不同外形规格。软体和服务部分包括影像处理软体、维护服务和培训服务，以支援实施和长期性能。耗材通常能带来持续收入，因此需要强大的供应链和品管。仪器是与临床团队互动的关键设备，需要良好的互通性。软体和服务决定使用者体验和生命週期价值。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将基于人工智慧的影像分析技术整合到萤光视镜中，用于即时病变检测
  • 用于增强胃肠道肿瘤可视化效果的近红外线萤光染料
  • 开发可携式萤光内视镜系统，以改善农村地区的照护现场诊断
  • 监管部门核准推进标靶萤光探针在早期大肠直肠癌筛检中的商业化进程
  • 将传统白光内视镜与多重萤光成像结合，以实现对病灶的全面评估
  • 一家生技公司与学术中心合作，开发个人化萤光导航手术通讯协定。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型萤光视镜市场

  • 消耗品
    • 生物探针
    • 萤光染料
  • 装置
    • 胶囊内视镜系统
    • 软式内视镜
    • 手持装置
  • 软体和服务
    • 影像处理软体
    • 维护服务
    • 培训服务

第九章萤光内视镜市场（依应用领域划分）

  • 胃肠内视镜检查
    • 大肠镜检查
    • 大肠镜检查
    • 食道镜检查
  • 妇科内视镜检查
    • 子宫镜检查
  • 肺内视镜检查
    • 支气管镜检查
  • 泌尿系统视镜检查
    • 膀胱镜检查

第十章 以最终用户分類的萤光视镜市场

  • 门诊手术中心
  • 诊所
  • 医院
    • 二级护理医院
    • 三级医院

第十一章萤光内视镜市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章萤光内视镜市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 各国萤光内视镜市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Olympus Corporation
    • Karl Storz SE & Co. KG
    • Stryker Corporation
    • Medtronic plc
    • Richard Wolf GmbH
Product Code: MRR-7E09162ED584

The Fluorescence Endoscopy Market is projected to grow by USD 16.38 billion at a CAGR of 8.20% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 8.72 billion
Estimated Year [2025] USD 9.45 billion
Forecast Year [2032] USD 16.38 billion
CAGR (%) 8.20%

A concise orientation to fluorescence endoscopy that highlights how imaging chemistry, device miniaturization, and clinical workflows are converging to redefine procedural visualization

Fluorescence-guided endoscopy has transitioned from a niche imaging adjunct into a clinical enabler that reshapes how clinicians visualize tissue pathology during invasive diagnostic and therapeutic procedures. Over the past decade, advances in targeted optical probes, miniaturized imaging hardware, and real-time image enhancement have collectively improved lesion detectability and intra-procedural decision-making. These technical advances are not simply incremental; they change clinical workflows by enabling more precise biopsies, sharper margin delineation during resections, and enhanced surveillance protocols for high-risk patients.

Clinicians and procurement teams now evaluate fluorescence endoscopy solutions through a combined lens of optical performance, probe chemistry, interoperability with existing endoscopy suites, and downstream training and maintenance requirements. From the perspective of innovation, we observe a convergence of biochemistry and engineering: molecular probes designed for specific biomarkers are being matched with imaging platforms optimized to maximize signal-to-noise while preserving ease of use in the procedural setting. As a result, adoption decisions increasingly weigh demonstrated clinical utility and operational fit rather than purely capital acquisition decisions.

This introduction sets the context for deeper analysis of technological inflection points, regulatory dynamics, reimbursement realities, and adoption barriers. The following sections unpack how these elements interact, how policy shifts and tariff environments alter supply chains, and which strategic moves can position stakeholders to capture clinical and commercial value from fluorescence endoscopy.

How advances in probe specificity, interoperable imaging platforms, AI-driven software, and service-centric commercial models are redefining clinical adoption dynamics

The landscape for fluorescence endoscopy is being reshaped by several transformative shifts that extend beyond hardware upgrades to encompass probe chemistry, software intelligence, and service delivery models. First, optical probe design has matured from broad-spectrum dyes to highly specific bioprobes that target molecular signatures, which improves contrast and reduces false positives; this shift supports more confident intra-procedural decisions and tighter integration with therapeutic workflows. Second, imaging platforms have become more modular and interoperable, enabling clinics to add fluorescence capability to existing endoscopy towers or to deploy compact handheld units for point-of-care procedures.

Concurrently, software and algorithmic enhancements have become pivotal; imaging software now emphasizes real-time enhancement, quantitative signal mapping, and integration with procedural documentation systems. Artificial intelligence and machine learning tools are increasingly applied to assist with lesion detection and to standardize interpretation, reducing operator variability and shortening learning curves. Service models are also evolving: vendors now bundle maintenance, training services, and remote software updates to ensure consistent performance and to drive recurring revenue streams.

These shifts collectively encourage cross-disciplinary collaboration among chemists, imaging engineers, and clinical teams, while also prompting hospital administrators to reconsider procurement strategies that balance capital investment against long-term service and consumable commitments. As a result, the fluorescence endoscopy landscape is moving toward platforms that prioritize clinical outcomes, operational efficiency, and scalable support structures.

Assessing how US tariff adjustments through 2025 have reshaped procurement, supplier strategies, and operational resilience across the fluorescence endoscopy value chain

The cumulative impact of United States tariffs enacted or adjusted through 2025 has introduced a range of operational and strategic considerations for stakeholders across the fluorescence endoscopy value chain. Tariff measures have affected the cost structure for imported imaging components, precision optics, and specialized manufacturing inputs used in both equipment and consumables. For manufacturers who source critical parts globally, these measures have necessitated a re-evaluation of supplier footprints, contracting terms, and inventory strategies to mitigate cost volatility and potential supply disruptions.

From a procurement perspective, healthcare providers have had to weigh the implications of higher import-related costs against clinical priorities and budget constraints. In some cases, hospitals and ambulatory centers extended asset life cycles or prioritized purchases that minimized exposure to affected supply chains. For smaller device vendors and probe developers, tariffs increased the pressure to localize production or to negotiate tariff pass-through arrangements with distributors, which altered margin profiles and investment timelines.

Regulatory and compliance teams faced additional administrative burdens as tariff-driven supplier changes required requalification of components and updates to device master records. Finally, the tariff environment accelerated conversations about nearshoring and strategic partnerships that prioritize supply resilience over short-term cost advantages. In aggregate, these effects shifted capital allocation, contractual commitments, and supply chain planning across the ecosystem, prompting more deliberate decisions around sourcing, pricing, and operational continuity.

Deep segmentation insights that map product types, clinical applications, and end-user requirements to strategic commercialization and clinical evidence priorities

Segment-specific dynamics reveal distinct pathways for product, application, and end-user adoption that should inform commercialization and clinical strategies. Based on Product Type, market activity differentiates between Consumables, Equipment, and Software and Services; the Consumables segment includes bioprobes and fluorescent dyes designed for targeted visualization and procedural specificity, while the Equipment segment comprises capsule endoscopy systems, flexible endoscopes, and handheld devices offering varied form factors for different clinical environments, and the Software and Services segment covers imaging software, maintenance services, and training services that support adoption and long-term performance. Each product group interacts with clinical workflows differently: consumables often drive recurring revenue and require robust supply chains and quality control, equipment represents the capital interface with clinical teams and needs clear interoperability, and software and services determine user experience and lifecycle value.

Based on Application, clinical uptake is organized around Gastrointestinal Endoscopy, Gynecological Endoscopy, Pulmonary Endoscopy, and Urological Endoscopy; within Gastrointestinal Endoscopy, procedural focus is on colonoscopy, enteroscopy, and esophagoscopy for lesion detection and surveillance, whereas Gynecological Endoscopy centers on hysteroscopy procedures for intrauterine visualization, Pulmonary Endoscopy emphasizes bronchoscopy for airway and peripheral lung assessment, and Urological Endoscopy concentrates on cystoscopy for bladder visualization. Clinical evidence and specialty training differ across these applications, which affects speed of adoption and the types of probes and imaging systems that clinicians prefer.

Based on End User, adoption patterns vary across ambulatory surgical centers, clinics, and hospitals; hospitals further segment into secondary care and tertiary care institutions, with tertiary centers generally driving early clinical validation and complex-case usage while ambulatory and clinic settings prioritize compact equipment, cost-effectiveness, and simplified training. Understanding how product type maps to clinical application and end-user requirements clarifies where to focus clinical evidence generation, which service bundles will increase utilization, and how distribution strategies should be tailored to each buyer profile.

Regional strategic outlook outlining how the Americas, Europe Middle East & Africa, and Asia-Pacific differ in clinical adoption, procurement, and regulatory drivers

Regional dynamics shape both the commercial and clinical trajectories of fluorescence endoscopy, driven by differing healthcare infrastructure, regulatory regimes, and clinical practice patterns. The Americas exhibit strong procedural volumes and established procedural reimbursement frameworks in many healthcare systems, which supports early adoption of advanced imaging modalities; the region also features a competitive landscape for equipment suppliers and a concentration of clinical research centers that validate new applications. In contrast, Europe, Middle East & Africa displays a heterogeneous mix of adoption drivers, where countries with robust tertiary care networks and supportive regulatory pathways accelerate clinical evaluation, while emerging healthcare systems prioritize cost-effective models and scalable service arrangements.

Asia-Pacific presents a blend of rapid hospital modernization, sizeable patient populations, and targeted national investments in advanced diagnostics; this region often leads in adoption of compact and cost-efficient devices suited to high-throughput clinical settings, and it increasingly contributes to multicenter clinical studies. Supply chain considerations vary by region: local manufacturing capabilities and trade policy influence sourcing decisions and inventory strategies, while regional training infrastructure affects the pace at which clinicians integrate fluorescence techniques into procedural practice. These geographic contrasts mean that commercialization approaches, clinical engagement plans, and regulatory strategies must be regionally adapted to align with payers, procurement policies, and clinician preferences.

Insightful synthesis of company strategies showing how partnerships, platform integration, and service-led differentiation are shaping competitive positioning and clinical validation

Company-level behaviors provide insight into how the ecosystem is evolving through collaboration, vertical integration, and specialization. Technology providers with established endoscopy portfolios increasingly seek to embed fluorescence-capable modules into existing platforms to leverage installed bases and to simplify adoption for hospital procurement teams. Specialist consumable developers focus on probe chemistry and regulatory pathways, prioritizing clinical partnerships to demonstrate specificity and safety in targeted applications. Software players concentrate on image processing, workflow integration, and interoperability standards to ensure their solutions can be adopted across diverse hardware configurations.

Strategic partnerships and licensing arrangements have become common, as device makers collaborate with biochemistry firms to co-develop probes that are optimized for proprietary imaging wavelengths and signal-processing algorithms. Service differentiation-particularly in training, remote diagnostics, and maintenance-has emerged as a competitive lever, with vendors offering multi-year service agreements and clinician education packages to reduce friction during adoption. Meanwhile, some players pursue modular designs and open interfaces to attract third-party software innovators, acknowledging that an ecosystem approach can accelerate feature development and clinical validation. Together, these company-level strategies influence product road maps, commercial models, and the types of clinical evidence generated across the sector.

Actionable recommendations for executives that focus on evidence generation, supply chain resilience, interoperable software, service differentiation, and targeted commercialization tactics

Industry leaders can take specific, measurable steps to strengthen market position, accelerate clinical adoption, and manage operational risk. First, prioritize integrated evidence generation programs that pair probe-specific clinical trials with device performance assessments to create clear, application-specific value propositions for clinicians and payers. Second, diversify supply chains and adopt tiered sourcing strategies for critical optical and electronic components to reduce tariff exposure and to improve inventory resilience without materially increasing working capital.

Third, invest in interoperable imaging software and open APIs to ensure rapid integration with hospital information systems and to enable third-party algorithm developers to extend functionality. Fourth, design service bundles that include structured training, protocol standardization, and predictive maintenance to lower operational barriers and to enhance long-term revenue streams. Fifth, pursue targeted commercialization approaches by aligning product form factors with end-user needs-compact, cost-efficient systems for ambulatory clinics and advanced modular platforms for tertiary centers. Finally, engage early with regulatory authorities and payers to clarify evidence requirements and reimbursement pathways; proactive dialogue can shorten adoption cycles and reduce uncertainty for clinical stakeholders. Taken together, these actions balance near-term operational resilience with long-term clinical and commercial viability.

A rigorous mixed-methods research approach combining clinician interviews, supply chain analysis, regulatory review, and cross-validated secondary sources to ensure robust insights

The research methodology combines structured qualitative inquiry with systematic secondary analysis to ensure balanced, validated insights. Primary research included in-depth interviews with clinicians across gastroenterology, pulmonology, gynecology, and urology to understand procedural needs, pain points, and clinical decision thresholds. Complementing clinician input, interviews with procurement specialists, biomedical engineers, and service managers provided perspectives on operational constraints, capital planning, and maintenance requirements. These primary inputs were triangulated with regulatory filings, peer-reviewed clinical literature, patent landscapes, and product specification documents to verify technical capabilities and safety profiles.

Supply chain and tariff impacts were assessed through a combination of trade data review, supplier mapping, and interviews with manufacturing and procurement leads to identify critical component dependencies. Commercial dynamics and company strategies were evaluated using a synthesis of investor filings, press releases, and partnership announcements, while anonymized customer feedback informed service and training assessments. Throughout the process, data triangulation and cross-validation steps were applied to reconcile discrepancies and to ensure that conclusions reflect convergent evidence rather than single-source assertions. This mixed-methods approach yields actionable insights grounded in clinical practice and operational realities.

A definitive conclusion emphasizing the need for aligned clinical validation, operational preparedness, and cross-disciplinary collaboration to realize fluorescence endoscopy's potential

Fluorescence endoscopy stands at an inflection point where technological advances, evolving clinical evidence, and shifting commercial models converge to create expanded clinical utility and fresh business opportunities. The maturation of targeted probes and more flexible imaging platforms enables clinicians to perform more precise diagnostic and therapeutic procedures, while software advances and service models reduce the friction of adoption. At the same time, external pressures such as trade policy adjustments and supply chain reconfiguration require stakeholders to be more strategic about sourcing, partnerships, and capital allocation.

Decision-makers that align clinical validation efforts with practical implementation plans-investing in clinician training, interoperable systems, and resilient procurement strategies-will be best positioned to translate technical promise into routine clinical impact. The path forward favors cross-disciplinary collaboration among chemists, engineers, clinicians, and commercial teams, and it rewards organizations that deploy evidence-based commercialization strategies tailored to regional and end-user nuances. By focusing on demonstrable improvements in patient care, operational efficiency, and supplier resilience, stakeholders can navigate current headwinds and realize the potential that fluorescence-guided visualization offers across multiple procedural domains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-powered image analysis in fluorescence endoscopy for real-time lesion detection
  • 5.2. Expansion of near-infrared fluorescence dyes for enhanced visualization of gastrointestinal tumors
  • 5.3. Development of portable fluorescence endoscopy systems to improve point-of-care diagnostics in rural settings
  • 5.4. Regulatory approvals driving commercialization of targeted fluorescent probes for early colorectal cancer screening
  • 5.5. Integration of multiplexed fluorescence imaging with traditional white-light endoscopy for comprehensive lesion assessment
  • 5.6. Collaborations between biotech firms and academic centers to develop personalized fluorescence-guided surgical protocols

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fluorescence Endoscopy Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Bioprobes
    • 8.1.2. Fluorescent Dyes
  • 8.2. Equipment
    • 8.2.1. Capsule Endoscopy Systems
    • 8.2.2. Flexible Endoscopes
    • 8.2.3. Handheld Devices
  • 8.3. Software and Services
    • 8.3.1. Imaging Software
    • 8.3.2. Maintenance Services
    • 8.3.3. Training Services

9. Fluorescence Endoscopy Market, by Application

  • 9.1. Gastrointestinal Endoscopy
    • 9.1.1. Colonoscopy
    • 9.1.2. Enteroscopy
    • 9.1.3. Esophagoscopy
  • 9.2. Gynecological Endoscopy
    • 9.2.1. Hysteroscopy
  • 9.3. Pulmonary Endoscopy
    • 9.3.1. Bronchoscopy
  • 9.4. Urological Endoscopy
    • 9.4.1. Cystoscopy

10. Fluorescence Endoscopy Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals
    • 10.3.1. Secondary Care Hospitals
    • 10.3.2. Tertiary Care Hospitals

11. Fluorescence Endoscopy Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Fluorescence Endoscopy Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Fluorescence Endoscopy Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Olympus Corporation
    • 14.3.2. Karl Storz SE & Co. KG
    • 14.3.3. Stryker Corporation
    • 14.3.4. Medtronic plc
    • 14.3.5. Richard Wolf GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. FLUORESCENCE ENDOSCOPY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. FLUORESCENCE ENDOSCOPY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. FLUORESCENCE ENDOSCOPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY BIOPROBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY BIOPROBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY BIOPROBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY BIOPROBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY BIOPROBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY BIOPROBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY FLUORESCENT DYES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY FLUORESCENT DYES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY FLUORESCENT DYES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY FLUORESCENT DYES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY FLUORESCENT DYES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY FLUORESCENT DYES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HANDHELD DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HANDHELD DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HANDHELD DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HANDHELD DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY IMAGING SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY IMAGING SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY IMAGING SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY IMAGING SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY TRAINING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY TRAINING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY TRAINING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY TRAINING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY TRAINING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY TRAINING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COLONOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY ENTEROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY ENTEROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY ENTEROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY ENTEROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY ENTEROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY ENTEROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY ESOPHAGOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY ESOPHAGOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY ESOPHAGOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY ESOPHAGOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY ESOPHAGOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY ESOPHAGOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HYSTEROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HYSTEROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HYSTEROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HYSTEROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY BRONCHOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY BRONCHOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY BRONCHOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY BRONCHOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY BRONCHOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY BRONCHOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CYSTOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CYSTOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CYSTOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CYSTOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CYSTOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CYSTOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL FLUORESCENCE ENDOSCOPY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PULMONARY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE FLUORESCENCE ENDOSCOPY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST FLUORESCENCE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST FLUORESCENCE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)

TAB